A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers

por Starks, David, Rojas‐Espaillat, Luis, Meissner, Tobias, Elsey, Rachel, Xu, Bing, Koenen, Maria, Feng, Shelley, VanOosbree, Annika, Slunecka, John, Lee, John, Williams, Casey B.
Publicado 2023

UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells

por Sane, Sanam, Hafner, Andre, Srinivasan, Rekha, Masood, Daniall, Slunecka, John l., Noldner, Collin J., Hanson, Alex D., Kruisselbrink, Taylor, Wang, Xuejun, Wang, Yiyang, Yin, Jun, Rezvani, Khosrow
Publicado 2018

Implementation and implications for polygenic risk scores in healthcare

por Slunecka, John L., van der Zee, Matthijs D., Beck, Jeffrey J., Johnson, Brandon N., Finnicum, Casey T., Pool, René, Hottenga, Jouke-Jan, de Geus, Eco J. C., Ehli, Erik A.
Publicado 2021